CIT-Logo-White Created with Sketch.

MENU
Device Guides
Trial Guide
Centers
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

Search Results

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

cit | Article | August/September 2009

European Perspective of Percutaneous Mitral Leaflet Repair

An overview of the EVEREST trials and the MitraClip system used to treat mitral regurgitation.

By Olaf Franzen, MD; Sven Meyer, MD; Stephan Baldus, MD; Anjelika Costard-Jäckle, MD; and Thomas Meinertz, MD

cit | Article | August/September 2009

Transcatheter Valve Therapies

By Ted E. Feldman, MD, FSCAI - Chief Medical Editor

cit | Article | September 2007

CTA Case Studies

Clinical utility of cardiac CTA in patients with previous CABG.

By Jason T. Bradley, MD; Mitchell N. Rashid, MD; and Matthew W. Watkins, MD, FACC

Sponsored by Stryker Peripheral Vascular

cit | Article | March/April 2026

The PERSEVERE Trial: Advancing Evidence in High-Risk PE

Global Principal Investigators discuss the design and impact of a randomized trial evaluating the FlowTriever System versus standard of care for high-risk pulmonary embolism.

With Stavros V. Konstantinides, MD, PhD, and Nicolas Meneveau, MD, PhD

Advertisement

cit | Article | September/October 2024

Contemporary Mitral TEER and Expanding Indications

Expanding beyond the green zone.

By Nidhish Tiwari, MD; Muhammad Asim Shabbir, MD; and Nidhi Madan, MD, MPH

Sponsored by Penumbra, Inc.

cit | Article | March/April 2026

From ACS to PE: Transforming Patient Care Through Innovative Therapies

With Michele Morosato, MD; Sylwia Slawek-Szmyt, MD, PhD, FESC; and Mark Mariathas, BM, BSc (Hons), DM, MRCP

cit | Article | March/April 2023

Contemporary Trends in Diagnosis and Management of Pulmonary Embolism

A review of the identification and classification of acute pulmonary embolic disease and modern management strategies.

By Daniel Heikali, MD, and Suhail Dohad, MD

cit | News | August 28, 2022

FRAME-AMI Trial Compares FFR and Angiography to Select Non–Infarct-Related Artery Lesions for PCI in Patients With AMI and Multivessel Disease

August 28, 2022—Findings from the FRAME-AMI study found that selection of non–infarct-related artery (non-IRA) lesions for percutaneous coronary intervention (PCI) using fractional flow reserve (FFR) is superior to routine angiography-based selection in patients with acute myocardial infarction (AMI) and multivessel disease, announced the European Society of Cardiology.

cit | Article | September/October 2010

PFO as Seen From the Brain

A neurological view of patent foramen ovale and closure.

By Lars Thomassen, MD, PHD, and Ulrike Waje-Andreassen, MD, PHD

cit | News | September 27, 2015

Greater Benefit Seen With Multiple Arterial CABG Versus PCI in Long Term

September 25, 2015—Findings from a study that sought to investigate longer-term outcomes including the potential added advantage of multiarterial coronary artery bypass graft (MA-CABG) compared with percutaneous coronary intervention (PCI) were published by Robert H. Habib, PhD, et al in the Journal of the American College of Cardiology (2015;66:1417–1427).  

cit | Article | March/April 2023

Mechanisms of Transcatheter Valve Degeneration

A translational perspective.

By Hacina Gill, BSc; David Meier, MD; Althea Lai, BSc; Geoffrey W. Payne, MSc, PhD; and Stephanie L. Sellers, MSc, PhD

cit | Article | July/August 2014

CoreValve: Assessing the Clinical Trials

A review of trial patient selection and results, as well as clinical implications.

By Steven J. Yakubov, MD, FACC, and Kyle Feldmann, MD

cit | Article | March/April 2014

Considerations for ASD Closure

Understanding the devices and proper anatomic evaluation to prevent and manage possible complications.

By Paul Poommipanit, MD, FSCAI, FACC, and Zahid Amin, MD, FSCAI, FAAP, FACC, FAHA

cit | News | November 19, 2017

Utility of ACC/AHA Lesion Classification Studied as Predictor of PCI Outcomes

November 20, 2017—In a study that was published online in Catheterization and Cardiovascular Interventions, James Theuerle, MBBS, et al investigated correlations between the American College of Cardiology/American Heart Association (ACC/AHA) coronary lesion classification and the clinical outcomes seen in contemporary percutaneous coronary intervention (PCI).

cit | News | November 18, 2015

TATORT-NSTEMI Trial Shows Thrombus Aspiration Does Not Improve 12-month Outcomes

November 19, 2015— The European Society of Cardiology announced the publication of findings from the TATORT-NSTEMI trial showing that thrombus aspiration before percutaneous coronary intervention (PCI) does not improve 12-month clinical outcomes in patients with non-ST-elevation myocardial infarction (NSTEMI).

cit | News | December 7, 2017

Postmarket JUPITER Registry Evaluates Second-Generation JenaValve to Treat Aortic Regurgitation

December 8, 2017—One-year outcomes from the postmarket JUPITER registry evaluating the safety and efficacy of transapical aortic valve implantation using the second-generation JenaValve transcatheter heart valve (JenaValve Technology GmbH) for aortic regurgitation were published by Miriam Silaschi, MD, et al online ahead of print in Catheterization and Cardiovascular Interventions (CCI).

cit | Article | January/February 2021

Appraising the Role of PFO Closure

A review of updated trial data, available devices, and application of patent foramen ovale closure.

By Krishna S. Kallakuri, MD, and Rajeev L. Narayan, MD

cit | Article | September/October 2011

The Transapical Route for TAVR

Recent data regarding transapical access for transcatheter aortic valve replacement, as well as the devices used in this procedure.

By Rafal Dworakowski, MD, PhD, and Olaf Wendler, MD, PhD, FRCS

Sponsored by CeloNova BioSciences, Inc.

cit | Article | September/October 2020

Clinical Decision-Making for PCI Patients During the COVID-19 Pandemic

With Aloke Finn, MD; Rajiv Jauhar, MD, FACC, FSCAI; and S. Jay Mathews, MD, MS, FACC

cit | News | November 9, 2015

Medtronic's Micra Transcatheter Pacing System Meets Safety and Effectiveness Endpoints in Global Trial

November 9, 2015—Medtronic plc announced the publication of data demonstrating that the company’s Micra transcatheter pacing system (TPS) was successfully implanted in 99.2% of patients in the trial and met its safety and effectiveness endpoints with wide margins.

Advertisement

Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button